You have just given 4 very good reasons why the s/p is at the current - recognising these factors it is very debatable whether the shares are cheap, or still over-valued
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025